study finds Indoor air contains greater diversity of airborne fungi than previously thought
On Jun. 5, 2026, researchers from Imperial College London have conducted the UK’s largest-ever longitudinal study of indoor…
-
-
U.S. FDA approves Celltrion’s OMLYCLO® (omalizumab-igec) as the first and only biosimilar with interchangeability designation referencing XOLAIR®
On Mar. 9, 2025, Celltrion announced the U.S. Food and Drug Administration (FDA) approved OMLYCLO® (omalizumab-igec) as the first and…
-
Agriculture | Biotechnology | Chemistry | Diagnostics | Environmental | Medicine | Therapeutics | Vaccine | Women's Health
How healthy is your state? IHME’s briefings provide insights
On Jan. 10, 2025, the Institute for Health Metrics and Evaluation (IHME) reported that when it comes to…
-
First new treatment for asthma attacks in 50 years
On Nov. 28, 2024, scientists from King’s College London reported that an injection given during some asthma and…
-
Agriculture | Biotechnology | Chemistry | Diagnostics | Environmental | EPA | Therapeutics
Air pollution accounted for 8.1 million deaths globally in 2021, Becoming the second leading risk factor for death
On Jun. 19, 2024, the Institute for Health Metrics and Evaluation (IHME) released a comprehensive new report that…
-
NIH study linked specific outdoor air pollutants to asthma attacks in urban children
On Jan. 4, 2023, a National Institutes of Health funded study reported that moderate levels of two outdoor…
-
Food allergy associated with lower risk of SARS-CoV-2 infection
On Jun. 1, 2022, the U.S. National Institutes of Health (NIH) announced that an NIH funded study had…
-
NIH established new childhood asthma clinical research network
On Apr. 23, 2021, the National Institute of Allergy and Infectious Diseases (NIAID) announced that it had awarded…
-
Asthma drug budesonide shortened recovery time in non-hospitalised patients with COVID-19
On Apr. 12, 2021, Oxford University reported that early treatment with inhaled budesonide shortened recovery time by a…
-
Risk of severe Covid-19 from asthma and other respiratory diseases modestly increased
On Apr. 1, 2021, Oxford University scientists announced they had published in The Lancet Respiratory Medicine, a study…
-
FDA approved Trelegy Ellipta as first once-daily single inhaler triple therapy for treatment of both asthma and COPD in the U.S.
On Sept. 10, 2020, GlaxoSmithKline and Innoviva announced the U.S. Food and Drug Administration (FDA) had approved a…
-
NIH study to determine incidence of novel Coronavirus infection in US children began
On May 4, 2020, a National Institutes of Health (NIH) study to help determine the rate of novel…
-
deCODE reported a genome-wide association meta-analysis of 69,189 cases and 702,199 controls from Iceland and UK biobank
On Jan. 20, 2020, deCODE genetics reported a genome-wide association meta-analysis of 69,189 cases and 702,199 controls from…
-
Cleveland Clinic study identified genetic anomaly associated with poor response to common asthma treatment
On Jan. 13, 2020, a new Cleveland Clinic study uncovered a genetic anomaly associated with poor response to…
-
Masonic Cancer Center joined the National Institute of Environmental Health Sciences Study, Human Health Exposure Analysis Resource (HHEAR)
On Dec. 13, 2019, the Masonic Cancer Center joined the National Institute of Environmental Health Sciences Study, Human…
-
Government of Canada and partners invested $18 million in crucial microbiome research
On Jan. 30, 2019, the Government of Canada announced an investment of $18 million over five years in…
-
Biotechnology | Disease | FDA | Therapeutics
Genentech drug Xolair (omalizumab) was approved
On Jun. 20, 2003, Genentech drug Xolair (omalizumab) was approved by the U. S. Food and Drug Administration…
-
International consortium launched genetic variation mapping project
On Oct. 29, 2002, an international research consortium launched a $100 million public-private effort to create the next…
-
Stanford researchers identified a novel gene family involved in asthma
On Nov. 19, 2001, researchers at Lucile Packard Children’s Hospital at Stanford announced they had identified a novel…
-
Biotechnology | Cardiology | Disease | Energy | Environmental | EPA | Neurology
The Environmental Protection Agency took final step in phaseout of leaded gasoline
On Jan. 29, 1996, Environmental Protection Agency (EPA) Administrator Carol M. Browner took the last steps concluding a…
-
Biology | Disease | Environmental | EPA | Neurology | U.S. Congress
The EPA sets new limits on lead in gasoline
On Mar. 4, 1985, the Environmental Protection Agency (EPA) Administrator Lee M. Thomas announced final standards to cut…
-
Stanford Hospital Department of Pharmacology faculty expressed opposition to aerial spraying of Malathion to combat Mediterranean fruit fly
In 1980, faculty members in the Stanford University’s Department of Pharmacology publicly expressed their opposition to the proposed…
-
CDC | Disease | Energy | Environmental | EPA | Life Science History | Neurology
The CDC revealed blood lead levels related to gasoline exposure, leading to fuel changes by the EPA
In 1976, the U.S. Centers for Disease Control and Prevention’s (CDC) Environmental Services Division revealed blood lead levels…
-
Disease | Energy | Environmental | EPA | Life Science History | Neurology | U.S. Congress | Women's Health
The Environmental Protection Agency required the phase-out of lead in gasoline
On Nov. 28, 1973, the Environmental Protection Agency (EPA) Administrator Russell E. Train announced the final regulations to…
-
The US Environmental Protection Agency was established
On Dec. 2, 1970, the US Environmental Protection Agency (EPA) was established by President Richard Nixon with an…
-
Biology | Disease | Environmental | EPA | FDA | Life Science History | Neurology | U.S. Congress
William Mansfield Clark alerted the public to the dangers of tetraethyl lead in gasoline
In 1923, William Mansfield Clark from the U.S. Department of Agriculture alerted the public to the dangers of…
